-
M. Le Borgne, P. Marchand, B. Delovoye-Seiller, J.-M. Robert, S. Robert-Piessard, G. Le Baut, R. W. Hartman, und M. Palzer. New selective nonsteroidal aromatase inhibitors: Synthesis and inhibitory activity of 2,3 or 5-(α-azolybenzyl)-1H-indoles. Bioorg. Med. Chem. Lett. 1999, 9, 333-336.
-
R. W. Hartmann, M. Hector, B. G. Wachall, A. Palusczak, M. Palzer, V. Huch, und M. Veith. Synthesis and evaluation of 17-aliphatic heterocycle substituted steroidal inhibitors of 17α-hydroxylase / C17-20-lyase (P450 17). J. Med. Chem. 2000, 43, 4437-4445.
-
M. Recanatini, A. Bisi, A. Cavalli, F. Belluti, S. Gobbi, A. Rampa, P. Valenti, M. Palzer, A. Palusczak, und R. W. Hartmann. A new class of non steroidal aromatase inhibitors: Design and synthesis of chromone and xanthone derivatives, and inhibition of P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase. J. Med. Chem. 2001, 44, 672-680.
-
P. Marchand, M. Le Borgne, M. Palzer, G. Le Baut, und Hartmann R. W. Preparation and pharmacological profile of 7-(α-Azolylbenzyl)-1H-Indoles and indolines as new aromatase inhibitors. Bioorg. Med. Chem. Lett. 2003, 13, 1553-1555.
-
Logé, C., Le Borgne, M., Marchand, P., Robert, J.-M., Palzer, M., Hartmann, R.W., Three-dimensional model of cytochrome P450 human aromatase and docking studies in to the active site, Bioorg. Med. Chem., submitted
|
